T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies
Open Access
- 14 February 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 146
Abstract
The senescence of the immune system and the risk of cancer both increase with aging. Age itself entails changes in the immune system, which are related with a decrease in thymic output of naïve lymphocytes, the accumulation of chronic antigenic load, notably chronic viral infections such as cytomegalovirus, and replicative senescence of lymphocytes. These changes could eventually contribute to cancer risk and to response to cancer treatment but several confounding factors make it difficult to draw a picture of causal relationships. Studies in diverse human populations could contribute to clarify these complex relationships. Here we summarize the current knowledge about the senescence of the T cells, the relationship with CMV infection, cancer and cancer treatment and the results of a series of studies performed in Cuba, a population characterized by the unusual combination of long life expectancy together with the high antigenic load, including cytomegalovirus infection, typical of a tropical country. Although immunosenescence affects almost all components and function of the immune response its most salient feature is a decrease in numbers and proportions of naïve CD8 T lymphocytes together with an accumulation of highly differentiated effector-memory CD8 T lymphocytes. These features were confirmed in the Cuban studies but a clear gender effect also appeared. As the global population ages, a rapid increase in elderly people with malignant tumors can be expected; therefore, a comprehensive evaluation of patient’s immune status would provide an appropriate support for determining whether patients are going to be benefitted with immunotherapy.Keywords
This publication has 43 references indexed in Scilit:
- A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer PatientsClinical Cancer Research, 2016
- CD57 in human natural killer cells and T-lymphocytesCancer Immunology, Immunotherapy, 2016
- Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patientsCancer Immunology, Immunotherapy, 2015
- CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancerExpert Review of Vaccines, 2015
- Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgeryOncoImmunology, 2015
- Immunosenenescence: Role of cytomegalovirusExperimental Gerontology, 2014
- CMV Latent Infection Improves CD8+ T Response to SEB Due to Expansion of Polyfunctional CD57+ Cells in Young IndividualsPLOS ONE, 2014
- Diagnosis and Screening for Cytomegalovirus Infection in Pregnant Women in Cuba as Prognostic Markers of Congenital Infection in NewbornsThe Pediatric Infectious Disease Journal, 2010
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cellsBlood, 2003
- Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoformsEuropean Journal of Immunology, 1999